The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine...

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this...

Sterling Pharma Solutions, a globally active CDMO based in Birmingham, England, has kicked off a $2.1 million expansion project to increase chemical and analytical...

UK CDMO Sterling Pharma Solution has announced the next phase of a multi-year investment at its site in Dudley. The £10m project will include new process development...

UK CDMO Sterling Pharma Solutions has acquired compatriot firm ADC Biotechnology, a specialist in antibody drug conjugates (ADCs). The acquisition follows Sterling’s...

CDMO Sterling Pharma Solutions has formed a strategic partnership with ADC Biotechnology, a UK-based specialist in the discovery, development and manufacture of antibody...